Stock Events

Stock Events

Hyperion DeFi 

$3.25
92
-$0.02-0.61% Thursday 20:00

Statistics

Day High
3.27
Day Low
2.94
52W High
17.18
52W Low
0.85
Volume
454,077
Avg. Volume
383,349
Mkt Cap
26.32M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q1 2025
Q2 2025
Q3 2025
Next
-7.2
-4.36
-1.52
1.32
Expected EPS
1.32
Actual EPS
N/A

Financials

-87,400%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
114,000Revenue
-99.64MNet Income

Analyst Ratings

$6.13Average Price Target
The highest estimate is 8.25.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HYPD. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap237.61B
Novartis, through its Alcon division, provides a broad portfolio of eye care products, directly competing with Eyenovia's therapeutic solutions.
Bausch Health Companies
BHC
Mkt Cap2.62B
Bausch Health Companies, through its Bausch + Lomb segment, offers products that compete in the same eye health categories as Eyenovia.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its Vision Care division, competes in the eye health market, offering products that could rival Eyenovia's treatments.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals provides treatments for eye diseases, including Eylea, directly competing with Eyenovia's eye therapy solutions.
Alcon
ALC
Mkt Cap36.88B
Alcon focuses on eye care products across a wide range of areas, directly competing with Eyenovia's innovative eye therapies.
Pfizer
PFE
Mkt Cap140.15B
Pfizer offers various pharmaceutical products, including treatments for eye conditions, competing with Eyenovia's therapeutic approach.
Rogers
ROG
Mkt Cap1.57B
Roche, through its ophthalmology division, develops treatments for eye diseases, competing with Eyenovia's focus on eye care solutions.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical Industries offers generic and specialty medicines, including ophthalmic products, competing with Eyenovia's niche in eye care.

About

A U.S.-based firm pivoting from ophthalmic drug-delivery tech (Optejet) to becoming the first Nasdaq-listed U.S. company with a cryptocurrency treasury denominated in HYPE tokens from the Hyperliquid blockchain; also operates a validator (“Kinetiq × Hyperion”) and continues DeFi staking strategies alongside ongoing development of Optejet UFD™ for eye care.
Show more...
CEO
Mr. Hyunsu Jung
Employees
13
Country
US
ISIN
US30234E2037

Listings

XNAS
US
HYPD
F
DE
B0U.F
BOATS
BOATS
HYPD.BOATS

0 Comments

Share your thoughts

FAQ

What is Hyperion DeFi stock price today?▼
The current price of HYPD is $3.25 USD — it has decreased by -0.61% in the past 24 hours. Watch Hyperion DeFi stock price performance more closely on the chart.
What is Hyperion DeFi stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Hyperion DeFi stocks are traded under the ticker HYPD.
Is Hyperion DeFi stock price growing?▼
HYPD stock has fallen by -4.97% compared to the previous week, the month change is a +7.97% rise, over the last year Hyperion DeFi has showed a +192.79% increase.
What is Hyperion DeFi market cap?▼
Today Hyperion DeFi has the market capitalization of 26.32M
When is the next Hyperion DeFi earnings date?▼
Hyperion DeFi is going to release the next earnings report on May 07, 2026.
What were Hyperion DeFi earnings last quarter?▼
HYPD earnings for the last quarter are 0.05 USD per share, whereas the estimation was -7.2 USD resulting in a +100.69% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Hyperion DeFi revenue for the last year?▼
Hyperion DeFi revenue for the last year amounts to 114,000 USD.
What is Hyperion DeFi net income for the last year?▼
HYPD net income for the last year is -99.64M USD.
How many employees does Hyperion DeFi have?▼
As of April 03, 2026, the company has 13 employees.
When did Hyperion DeFi complete a stock split?▼
The last stock split for Hyperion DeFi was on February 03, 2025 with a ratio of 1:80.
Where is Hyperion DeFi headquartered?▼
Hyperion DeFi is headquartered in New York, US.